Q9976 Ferric Pyrophosphate Citrate — HCPCS Reimbursement

HCPCS Level II code Q9976 denotes an injection of ferric pyrophosphate citrate solution delivering 0.1 mg of iron. This injectable iron formulation is clinically relevant for patients needing parenteral iron replacement, particularly those undergoing hemodialysis or receiving infusion-based therapies. Nationally, accurate coding for specialty injectable iron products affects coverage determinations, medical record accuracy, and payment pathways across public and commercial payers.

This analysis covers major payers, including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for Q9976, typical sites of service where the product is administered, and what to expect when billing this HCPCS Level II code. The publication summarizes available benchmarks and common payer coverage patterns, highlights relevant policy updates affecting billing and reimbursement, and situates the code within infusion and dialysis service lines. Data not available in the input is clearly noted where applicable. The content is intended for coding professionals, revenue cycle staff, and clinical managers seeking a national-level briefing on the use and billing implications of HCPCS Level II code Q9976.

Billing Code Overview

HCPCS Level II code Q9976 represents an injection of ferric pyrophosphate citrate solution, providing 0.1 mg of elemental iron per listed unit. This product is used to deliver intravenous or dialysate-associated iron supplementation for patients requiring iron replacement.

Service type: Injectable iron therapy
Typical site of service: Hospital outpatient infusion centers, outpatient dialysis units, and other infusion settings where parenteral iron is administered

Clinical Context

A typical patient is a maintenance hemodialysis recipient with chronic kidney disease on an established outpatient dialysis regimen who requires intravenous iron replacement to manage dialysis-related iron losses and maintain hemoglobin targets. The medication Q9976 (injection, ferric pyrophosphate citrate solution, 0.1 mg of iron) is administered during a hemodialysis treatment session via the dialysis circuit or an intravenous line under the supervision of dialysis nursing staff. Clinical workflow: pre-dialysis review of recent hemoglobin, transferrin saturation (TSAT), and ferritin values; confirmation of prescription and dose by the nephrologist or advanced practice provider; verification of patient identity and dialysis access; aseptic preparation and administration of the ferric pyrophosphate citrate solution during the dialysis session; documentation of lot number, dose, time, and any immediate adverse reactions in the dialysis record and medication administration record; post-administration monitoring for hypotension, hypersensitivity, or infusion reactions; routine follow-up labs to guide subsequent iron dosing and erythropoiesis-stimulating agent adjustments.

Coding Specifications

Modifier	Description	When to Use
`59`	Distinct procedural service	When this injectable iron administration is distinct from other services performed on the same day and needs separation from other procedures.

Taxonomy Code	Specialty	Notes
`207RN0401X`	Registered Nurse	Dialysis nurses commonly administer `Q9976` during hemodialysis sessions and document administration.
`363L00000X`	Nephrology	Nephrologists prescribe and oversee iron management for dialysis patients.
`362LP0800X`	Physician Assistant - Nephrology	PAs in nephrology clinics and dialysis units manage iron therapy orders and adjustments.
`207RH0000X`	Clinical Nurse Specialist	CNS in nephrology facilities may develop protocols and supervise iron administration.
`2084P0800X`	Nurse Practitioner - Nephrology	NPs manage iron dosing, monitoring, and follow-up in dialysis populations.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D63.1`	Anemia in chronic kidney disease	Primary indication for routine intravenous iron administration during hemodialysis to support erythropoiesis.
`N18.6`	End stage renal disease	Patients with ESRD on maintenance hemodialysis commonly receive `Q9976` as part of dialysis-related iron management.
`D50.9`	Iron deficiency anemia, unspecified	Iron replacement may be indicated when iron deficiency contributes to anemia; IV route used when oral therapy is ineffective or impractical.
`E83.10`	Disorder of iron metabolism, unspecified	Relevant when iron handling abnormalities necessitate parenteral iron therapy.
`T80.0XXA`	Infection following infusion, transfusion and therapeutic injection, initial encounter	Monitoring and documentation include vigilance for infusion-related infections or complications; included for coding potential adverse events.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used for standalone parenteral injections; may be used in outpatient settings when billing injectable iron administrations outside of bundled dialysis payment contexts.
`36415`	Collection of venous blood by venipuncture	Performed before or after dialysis for hemoglobin, ferritin, and TSAT laboratory monitoring related to iron therapy.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Used when an outpatient visit occurs for management of anemia and iron therapy decisions prior to ordering `Q9976` administration.
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnostic; initial, up to 1 hour	When iron therapy is administered as an IV infusion requiring time-based reporting in settings where infusion billing is appropriate.
`96374`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular	Alternative injection code for facility billing when applicable; selection depends on payer rules and site of service.
`96379`	Unlisted therapeutic, prophylactic, or diagnostic intravenous or intra-arterial injection or infusion	Used when no specific CPT code accurately describes a complex or uncommon method of parenteral iron administration that requires an unlisted code and supporting documentation.

OpenPayer

Summary & Overview

HCPCS Q9976: Ferric Pyrophosphate Citrate Injection, 0.1 mg Iron